Intravitreal versus subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular oedema
Completed
- Conditions
- Macular oedemaEye Diseases
- Registration Number
- ISRCTN67086909
- Lead Sponsor
- St Orsola Malpighi University Hospital Bologna (Italy)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
1. Patients aged between 61 and 74 years (mean 68.3), either sex
2. With type II diabetes mellitus
3. On insulin treatment
4. Presenting diffuse macular oedema without retinal-vitreous traction
Exclusion Criteria
1. History of focal/grid laser photocoagulation in the macula
2. Record of uveitis episodes
3. Previous ocular surgery, glaucoma and ocular hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity was assessed using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, measured every month until the end of follow-up.
- Secondary Outcome Measures
Name Time Method Macular thickness was measured by optical coherence tomography (OCT), measured every month until the end of follow-up.